More articles from Original Article

You have access
Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
Yubei Huang, Huan Wang, Zhangyan Lyu, Hongji Dai, Peifang Liu, Ying Zhu, Fengju Song and Kexin Chen

Cancer Biology & Medicine September 2022, 19 (9) 1375-1384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0758
You have access
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
Haoran Mu, Dongqing Zuo, Jie Chen, Zhigang Liu, Zhuo Wang, Liu Yang, Qihui Shi and Yingqi Hua

Cancer Biology & Medicine September 2022, 19 (9) 1397-1409; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0279
You have access
Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li

Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727
You have access
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen

Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130
You have access
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu

Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708
You have access
PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun

Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294
You have access
Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li

Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255
You have access
Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin

Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585
You have access
Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer
Ye Tian, Qiang Li and Yuan Pan

Cancer Biology & Medicine August 2022, 19 (8) 1274-1281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0108
You have access
BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu

Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

Main menu

User menu

Search

More articles from Original Article

Pages

Navigate

More Information

For Authors

Journal Services